Rare diseases
Investigational molecules
Locations
3115 Merryfield Row Suite 300, 92121-1174, United States
Erasca Inc. is focused on clinical research in unresectable and metastatic cutaneous melanoma, with particular attention to NRAS mutant disease. The sponsor’s active programme is centered on treatment options for patients with previously treated advanced melanoma.
The research activity spans multiple collaborating sites across several countries, reflecting a broad international interest in advanced melanoma care.
Erasca Inc. runs clinical trials in conditions such as Malignant melanoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
